Venous thromboembolism: prophylactic and therapeutic practice guideline

S Afr Med J. 2013 Feb 15;103(4 Pt 2):261-7. doi: 10.7196/samj.6706.

Abstract

Background: Pharmacological prophylactic anticoagulation in many countries, including South Africa, is under-prescribed. This has resulted in unacceptable rates of morbidity and mortality.

Method: The Southern African Society of Thrombosis and Haemostasis held a meeting to update the previous guideline and review new literature including guidelines from other societies. The following specialties were represented on the committees: anaesthetics, cardiology, clinical haematology, critical care, obstetrics and gynaecology, haematopathology, internal medicine, neurology, orthopaedic surgery and pulmonology. A draft document was presented at the meeting, which was then revised by consensus agreement. To avoid local bias, the guideline was adjudicated by recognised international external experts.

Results and conclusion: A concise, practical updated guideline for thromboprophylaxis and treatment in medical and surgical patients has been produced for South African conditions. It is hoped that this guideline will continue to improve anticoagulation practice in this country, which we believe will directly benefit patient outcomes.

Publication types

  • Practice Guideline

MeSH terms

  • Anticoagulants* / administration & dosage
  • Anticoagulants* / adverse effects
  • Benzimidazoles / administration & dosage
  • Benzimidazoles / adverse effects
  • Chemoprevention / methods
  • Dabigatran
  • Disease Management
  • Dose-Response Relationship, Drug
  • Drug Delivery Systems / methods
  • Drug Monitoring / methods
  • Drug Substitution / methods
  • Hemorrhage* / chemically induced
  • Hemorrhage* / prevention & control
  • Hemorrhage* / therapy
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Heparin, Low-Molecular-Weight / adverse effects
  • Humans
  • International Normalized Ratio
  • Morpholines / administration & dosage
  • Morpholines / adverse effects
  • Preoperative Care / methods*
  • Risk Assessment
  • Risk Factors
  • Rivaroxaban
  • Secondary Prevention / methods*
  • Thiophenes / administration & dosage
  • Thiophenes / adverse effects
  • Time Factors
  • Vena Cava Filters*
  • Venous Thromboembolism* / classification
  • Venous Thromboembolism* / diagnosis
  • Venous Thromboembolism* / prevention & control
  • Venous Thromboembolism* / therapy
  • beta-Alanine / administration & dosage
  • beta-Alanine / adverse effects
  • beta-Alanine / analogs & derivatives

Substances

  • Anticoagulants
  • Benzimidazoles
  • Heparin, Low-Molecular-Weight
  • Morpholines
  • Thiophenes
  • beta-Alanine
  • Rivaroxaban
  • Dabigatran